{"id":18589,"date":"2025-01-18T18:54:25","date_gmt":"2025-01-18T17:54:25","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=18589"},"modified":"2025-05-20T19:04:39","modified_gmt":"2025-05-20T18:04:39","slug":"world-drug-report-2024-issues-key-findings-and-conclusions","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2025\/01\/world-drug-report-2024-issues-key-findings-and-conclusions\/","title":{"rendered":"World Drug Report 2024 – Issues, Key Findings and Conclusions"},"content":{"rendered":"\n\n\n\n
\"\"<\/a><\/td>\n <\/p>\n

Contemporary issues on drugs<\/span><\/h1>\n

As well as providing an in-depth analysis of key developments and emerging trends in selected drug markets,\u00a0the Contemporary issues on drugs booklet<\/a>\u00a0looks at several other developments of policy relevance. The booklet opens with a look at the 2022 Taliban ban on the cultivation and production of and trafficking in drugs in Afghanistan and its implications both within the country and in transit and destination markets elsewhere. This is followed by a chapter examining the convergence of drug trafficking and other activities and how they affect natural ecosystems and communities in the Golden Triangle in South-East Asia. The chapter also assesses the extent to which drug production and trafficking are linked with other illicit economies that challenge the rule of law and fuel conflict. Another chapter analyses how the dynamics of demand for and supply of synthetic drugs vary when the gender and age of market participants are considered. The booklet continues with an update on regulatory approaches to and the impact of legalization on the non-medical cannabis market in different countries, and a review of the enabling environment that provides broad access to the unsupervised, \u201cquasi-therapeutic\u201d and non-medical use of psychedelic substances. Finally, the booklet offers a multi-dimensional framework on the right to health in the context of drug use; these dimensions include availability, accessibility, acceptability, quality, non-discrimination, non-stigmatization and participation.<\/td>\n<\/tr>\n

 <\/p>\n

\"\"<\/a><\/td>\n

\n

Key findings and conclusions<\/span><\/h1>\n

The Key findings and conclusions booklet<\/a>\u00a0provides an overview of selected findings from the analysis presented in the Drug market patterns and trends module and the thematic Contemporary issues on drugs booklet, while the\u00a0Special points of interest<\/a>\u00a0fascicle offers a framework for the main takeaways and policy implications that can be drawn from those findings.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Sources: <\/strong><\/span><\/p>\n

Issues:\u00a0 https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2024-contemporary-issues.html<\/strong><\/span><\/p>\n

Findings and Conclusions: https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2024-key-findings-conclusions.html<\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

  Contemporary issues on drugs As well as providing an in-depth analysis of key developments and emerging trends in selected drug markets,\u00a0the Contemporary issues on drugs booklet\u00a0looks at several other developments of policy relevance. The booklet opens with a look at the 2022 Taliban ban on the cultivation and production of and trafficking in drugs […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[73,68,82,64,120,20,119,40],"tags":[],"class_list":["post-18589","post","type-post","status-publish","format-standard","hentry","category-addiction","category-drug-use-various-effects","category-economic","category-health","category-mental-health","category-others","category-prevalence","category-prevention-research"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/18589","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=18589"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/18589\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=18589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=18589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=18589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}